Kintara Therapeutics Inc (NASDAQ: KTRA) started the day on Thursday, with a price increase of 4.71% at $0.16, before settling in for the price of $0.15 at the close. Taking a more long-term approach, KTRA posted a 52-week range of $0.08-$5.60.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
The Healthcare Sector giants’ yearly sales growth during the last 5-year period was 0.00%. Meanwhile, its Annual Earning per share during the time was 49.09%. This publicly-traded company’s shares outstanding now amounts to $55.30 million, simultaneously with a float of $55.20 million. The organization now has a market capitalization sitting at $8.60 million. At the time of writing, stock’s 50-day Moving Average stood at $0.1179, while the 200-day Moving Average is $1.4796.
Kintara Therapeutics Inc (KTRA) Ownership Facts and Figures
Now let’s turn our focus to how large-scale investors are working with this stock of the Biotechnology Industry. Kintara Therapeutics Inc’s current insider ownership accounts for 0.19%, in contrast to 0.58% institutional ownership.
Kintara Therapeutics Inc (KTRA) Earnings and Revenue Records
In the latest quarterly report released, which was put into the public domain on 6/30/2023, the organization reported -3.5 earnings per share (EPS) for the three months, lower than the consensus estimate (set at 0) by -3.5. Wall Street market experts anticipate that the next fiscal year will bring earnings of 0 per share during the current fiscal year.
Kintara Therapeutics Inc (NASDAQ: KTRA) Trading Performance Indicators
Let’s observe the current performance indicators for Kintara Therapeutics Inc (KTRA). It’s Quick Ratio in the last reported quarter now stands at 0.63. The Stock has managed to achieve an average true range (ATR) of 0.02.
In the same vein, KTRA’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -5.98.
Technical Analysis of Kintara Therapeutics Inc (KTRA)
If we take a close look at the recent performances of Kintara Therapeutics Inc (NASDAQ: KTRA), its last 5-days Average volume was 3.02 million that shows plunge from its year to date volume of 12.73 million. During the previous 9 days, stock’s Stochastic %D was recorded 38.50% While, its Average True Range was 0.0175.
Raw Stochastic average of Kintara Therapeutics Inc (KTRA) in the period of the previous 100 days is set at 34.89%, which indicates a major fall in contrast to 53.10% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 113.16% that was lower than 149.81% volatility it exhibited in the past 100-days period.
